By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) 

3550 General Atomics Court
Building 2, Room 503
San Diego  California  92121  U.S.A.
Phone: 858-455-3708 Fax: 858-455-3962


SEARCH JOBS








Company News
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At Biotech Showcase In San Francisco 12/22/2014 9:11:14 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Release: Study Further Validates Cell Therapy Approach To Reverse Type 1 Diabetes 12/18/2014 8:57:29 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At 26th Annual Piper Jaffray Healthcare Conference 11/20/2014 12:30:46 PM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Receives U.S. Patent Claiming Alternative Methods to Manufacture Pancreatic Progenitor Cells In Vitro 11/6/2014 9:32:01 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.)'s VC-01™ Investigational Stem Cell-Derived Islet Replacement Therapy Successfully Implanted Into First Patient 10/29/2014 8:28:02 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At Upcoming Stem Cell Meeting On The Mesa Conference 10/6/2014 10:26:35 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Awarded $16.6 Million Accelerated Development Pathway Grant From California Institute for Regenerative Medicine 9/11/2014 7:54:27 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development 8/21/2014 7:20:55 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces FDA Acceptance Of IND To Commence Clinical Trial Of VC-01™ Candidate Cell Replacement Therapy For Type 1 Diabetes 8/19/2014 7:53:57 AM
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Scores $5.4 Million Private Financing 8/8/2014 8:30:47 AM
123456
//-->